While the recent market dip has created bargains, some stocks have sufficiently lagged the market in the past year to warrant ...

Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...

If most of our work happens in the digital domain, why should our assistants only be flesh and blood analogues, asks Satyen K ...

Biotech stocks are among the few industry groups producing breakouts and buyable stocks in an uncertain market. Vertex stock ...

Omnicom and Interpublic today announced that each company's respective stockholders overwhelmingly approved Omnicom's previously announced acquisition of Interpublic at each company's Special Meeting ...

UATP, the global network that enables organizations to simplify payment processes and expand their payment capabilities, announced today the launch of its newest Issuer, TreviPay, designed to provide ...

China's economy tsar, Vice Premier He Lifeng, sought to reassure foreign CEOs of the country's business potential, describing ...

"They have conquered every market they've engaged," Huang said of Huawei.

Wang Xing, CEO of China's largest food delivery firm Meituan , said on Friday in a post-earnings call that the company is ...

The licensing pact adds a second so-called "triple agonist" to the Danish drugmaker's portfolio as competition with Lilly and other contenders heats up.

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

The latest trading day saw Vertex Pharmaceuticals (VRTX ... as it looks poised to eventually become the first healthcare company to top a $1 trillion valuation. Alkermes (ALKS) reported earnings ...